Home | DAIC

Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30- and 90-Days Following Hospital Discharge

New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure

November 9, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3 ...

November 09, 2022

News | Hypertension

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

November 9, 2022 — CinCor Pharma, Inc. announced the presentation today of Phase 2 data from its BrigHtn trial as part ...

November 09, 2022

Feature | Angiography | By Bhvita Jani

Interventional X-ray and Mobile C-arm Equipment Markets Had a Double-digit Recovery in 2021

The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026 ...

November 09, 2022

Sponsored Content

Feature | Thrombectomy Devices

Redefining PE and VTE Intervention

Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...

June 01, 2026

Feature | AHA

American Heart Association Honors Distinguished Scientists at AHA22

November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022). The ...

November 09, 2022

Tech tools are creating positive change in Cardiac MRI Software Market

Feature | Magnetic Resonance Imaging (MRI) | By Christine Book

AI-powered Software Solutions Enhance Cardiac Diagnostics

Interventional cardiologists know well the phrase “change is the only constant.” This is especially relevant as ...

November 09, 2022

Artificial intelligence-powered alternative data is driving novel and disruptive market research opportunities at a staggering clip amid category growth forecasts, prompting industries of every size and sort to capitalize on this strategy that’s ever evolving and innovating

Feature | Cardiovascular Business | By Merilee Kern, MBA

AI-Powered Alternative Data Driving Extreme Market Research Disruption

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...

November 09, 2022

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

In 2023, the DAIC/dicardiology.com team looks to enhance its educational offerings to build the resources you need and have been asking for.

Blog | Cardiovascular Business

Enhancing the Educational Experience

Reflecting back, 2022 has been a productive year. It brought with it many changes and challenges, but also brought back ...

November 09, 2022

New genomic therapies for cardiovascular disease are reaching the clinical trial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (AHA2022).

News | AHA

Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022

November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be ...

November 08, 2022

Robert J. Mentz, M.D., Associate Professor of Medicine, Chief, Heart Failure Section, Associate Program Director, Duke Cardiology Fellowship, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, image copyright Robert J. Mentz

News | AHA

TRANSFORM-HF Trial Found No Difference in Effectiveness Between 2 Common Loop Diuretics

November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication ...

November 08, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Julian D. Gillmore, M.D., Ph.D., Professor, University College London Centre for Amyloidosis, United Kingdom, image copyright University College London Centre for Amyloidosis

News | AHA

Novel Gene-Editing Therapy Shows Promise For Patients With Transthyretin Amyloid Cardiomyopathy

November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly ...

November 08, 2022

Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio suite of products across a range of clinical applications

News | AHA

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

November 08, 2022

Cardio StillShot enables 6x higher temporal resolution compared to conventional image reconstruction methods by detecting and correcting motion in the heart

News | Computed Tomography (CT)

Fujifilm Introduces Scenaria View Focus Edition CT Scanner with Cardio StillShot, a new Cardiac Motion Correction Feature

November 8, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

November 08, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment

News | AHA

Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing

November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results ...

November 07, 2022

A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective

News | AHA

New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective

November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

November 07, 2022

Petr Ostadal, M.D., Ph.D., Professor of Medicine, Department of Cardiology, Na Homolce Hospital, Czech Republic. Image copyright Na Homolce Hospital

News | AHA

Early Use of ECMO devices Did Not Improve Outcomes in People With Cardiogenic Shock

November 7, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) ...

November 07, 2022